Skip to main content

Thomas Fuchs, Dr.sc.

Equibles does not estimate personal net worth.

Get an email with a short summary when GeneDx Holdings Corp. publishes a filing, an earnings call transcript or a press release.

Get WGS alerts

About Thomas Fuchs, Dr.sc.

Thomas Fuchs, Dr.sc. is recorded as Board Member at GeneDx Holdings Corp. (WGS) since September 17, 2025. GeneDx Holdings Corp. reported in an 8-K filed September 18, 2025 that Thomas Fuchs, Dr.sc. was appointed Class I director, effective September 17, 2025. GeneDx Holdings Corp. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at GeneDx Holdings Corp. includes Eric Schadt (CEO and Board Member), Katherine Stueland (CEO and Board Member), Kevin Feeley (CFO) and 7 others.

“On September 17, 2025, the Board of Directors (the "Board") of GeneDx Holdings Corp., a Delaware corporation (the "Company"), appointed Thomas Fuchs, Dr.sc., effective immediately, as a Class I director on the Board with a term expiring at the Company's 2028 Annual Meeting of Stockholders.”
GeneDx Holdings Corp. Form 8-K, filed September 18, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at GeneDx Holdings Corp.

Recent activity